BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5598439)

  • 1. [On the efficacy of onosma in experimental hypertension].
    Larin AP; Aleutskiĭ NN
    Farmakol Toksikol; 1967; 30(6):694-6. PubMed ID: 5598439
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental pituitrin hypertension and its treatment with papaverine and dibazol in high altitude].
    Rakhimova IA
    Sov Zdravookhr Kirg; 1969; 6():26-9. PubMed ID: 5375019
    [No Abstract]   [Full Text] [Related]  

  • 3. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
    Haan D
    Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of cocaine on hypertension induced by dopamine (hydroxytyramine) and action on posthypophyse extracts on blood pressure effect induced by this dopamine previously treated with adrenalin antagonists].
    Hazard R; Renier-Cornec A
    C R Seances Soc Biol Fil; 1973; 167(2):226-8. PubMed ID: 4802783
    [No Abstract]   [Full Text] [Related]  

  • 5. Five-hour blood pressure check to assess hypertension not responding to conventional therapy.
    Barker LR
    Md Med J; 1986 Feb; 35(2):94-7. PubMed ID: 3633373
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological properties of aminoenanthylic acid].
    Gofman SM
    Farmakol Toksikol; 1968; 31(2):188-9. PubMed ID: 4386316
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controllable hypertension therapy with Tadip].
    Schütz E
    Med Klin; 1971 Jan; 66(4):121-6. PubMed ID: 5546736
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of an imidazole derivative on arterial blood pressure, hemodynamics and ventilation].
    Kochsiek K; Fritsche H
    Arzneimittelforschung; 1966 Sep; 16(9):1154-60. PubMed ID: 6014733
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs.
    Sironi G; Montagna E; Greto L; Bianchi G; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of coenzyme Q10 on experimental hypertension in rats and dogs.
    Igarashi T; Nakajima Y; Tanaka M; Otake S
    J Pharmacol Exp Ther; 1974 Apr; 189(1):149-56. PubMed ID: 4823289
    [No Abstract]   [Full Text] [Related]  

  • 11. [Animal experiment and clinical studies on the action mechanism of the antihypertensive agent guancydine].
    Werning C; Vetter W; Schweikert HU; Armbruster H; Fischer N; Trübestein G; Siegenthaler W
    Verh Dtsch Ges Inn Med; 1971; 77():1004-8. PubMed ID: 5170618
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of high-magnesium hip-sirup (Viroma) on experimentally induced and essential hypertension].
    Rigó J; Puchok I; Szelényi I
    Vopr Pitan; 1969; 28(4):12-6. PubMed ID: 5368107
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
    Sweet CS; Gross DM; Arbegast PT; Gaul SL; Britt PM; Ludden CT; Weitz D; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):558-66. PubMed ID: 6259323
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathomorphologic lesions of blood vessels in experimental pituitrin hypertension in rabbits.
    Sobis H; Szadowska A
    Arch Immunol Ther Exp (Warsz); 1967; 15(1):58-67. PubMed ID: 6048229
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihypertensive effect of an aqueous extract of the calyx of Hibiscus sabdariffa.
    Mojiminiyi FB; Dikko M; Muhammad BY; Ojobor PD; Ajagbonna OP; Okolo RU; Igbokwe UV; Mojiminiyi UE; Fagbemi MA; Bello SO; Anga TJ
    Fitoterapia; 2007 Jun; 78(4):292-7. PubMed ID: 17482378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between the chemical structure and hypotensive activity of a series of new benzimidazole and quinoxaline derivatives].
    Kovalev GV; Gofman SM; Ivanovskaia SV; Pan'shina MV; Petrov VI
    Farmakol Toksikol; 1973; 36(2):232-8. PubMed ID: 4791601
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.
    Carpi C; Dorigotti L
    Br J Pharmacol; 1974 Nov; 52(3):459P. PubMed ID: 4458870
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of leaf extract from Clerodendron colebrookianum on blood pressure in rats.
    Gupta M; Mazumder UK; Das S
    Indian J Exp Biol; 1994 Mar; 32(3):216-7. PubMed ID: 7915249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minoxidil use in proteinuric renal disease.
    Diskin CJ
    Acta Med Croatica; 2008 Feb; 62(1):93. PubMed ID: 18365509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.